Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1983 Apr;59(690):219–228. doi: 10.1136/pgmj.59.690.219

The lymphomas--current management.

T A Lister, J S Malpas
PMCID: PMC2417488  PMID: 6346302

Full text

PDF
219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonadonna G., Santoro A., Bonfante V., Valagussa P. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results. Cancer Treat Rep. 1982 Apr;66(4):881–887. [PubMed] [Google Scholar]
  2. Canellos G. P., Lister T. A., Skarin A. T. Chemotherapy of the non-Hodgkin's lymphomas. Cancer. 1978 Aug;42(2 Suppl):932–940. doi: 10.1002/1097-0142(197808)42:2+<932::aid-cncr2820420716>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  3. Canellos G. P., Skarin A. T., Rosenthal D. S., Moloney W. C., Frei E., 3rd Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Cancer Treat Rep. 1981;65 (Suppl 1):125–129. [PubMed] [Google Scholar]
  4. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  5. Chilcote R. R., Baehner R. L., Hammond D. Septicemia and meningitis in children splenectomized for hodgkin's disease. N Engl J Med. 1976 Oct 7;295(15):798–800. doi: 10.1056/NEJM197610072951502. [DOI] [PubMed] [Google Scholar]
  6. Dady P. J., McElwain T. J., Austin D. E., Barrett A., Peckham M. J. Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease. Br J Cancer. 1982 Jun;45(6):851–859. doi: 10.1038/bjc.1982.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DeVita V. T., Jr The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture. Cancer. 1981 Jan 1;47(1):1–13. doi: 10.1002/1097-0142(19810101)47:1<1::aid-cncr2820470102>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  8. Diehl V., Kirchner H. H., Burrichter H., Stein H., Fonatsch C., Gerdes J., Schaadt M., Heit W., Uchanska-Ziegler B., Ziegler A. Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep. 1982 Apr;66(4):615–632. [PubMed] [Google Scholar]
  9. Earl H. M., Sutcliffe S. B., Fry I. K., Tucker A. K., Young J., Husband J., Wrigley P. F., Malpas J. S. Computerised tomographic (CT) abdominal scanning in Hodgkin's disease. Clin Radiol. 1980 Mar;31(2):149–153. doi: 10.1016/s0009-9260(80)80141-3. [DOI] [PubMed] [Google Scholar]
  10. Easson E. C., Russell M. H. Cure of Hodgkin's Disease. Br Med J. 1963 Jun 29;1(5347):1704–1707. doi: 10.1136/bmj.1.5347.1704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HICKS E. B., RAPPAPORT H., WINTER W. J. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956 Jul-Aug;9(4):792–821. doi: 10.1002/1097-0142(195607/08)9:4<792::aid-cncr2820090429>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  12. Habeshaw J. A., Stuart A. E. Cell receptor studies on seven cases of diffuse histiocytic malignant lymphoma (reticulum cell sarcoma). J Clin Pathol. 1975 Apr;28(4):289–297. doi: 10.1136/jcp.28.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jaffe E. S., Shevach E. M., Frank M. M., Berard C. W., Green I. Nodular lymphoma--evidence for origin from follicular B lymphocytes. N Engl J Med. 1974 Apr 11;290(15):813–819. doi: 10.1056/NEJM197404112901501. [DOI] [PubMed] [Google Scholar]
  14. KAPLAN H. S. The radical radiotherapy of regionally localized Hodgkin's disease. Radiology. 1962 Apr;78:553–561. doi: 10.1148/78.4.553. [DOI] [PubMed] [Google Scholar]
  15. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  16. Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  17. Malpas J. S. Lymphomas in children. Semin Hematol. 1982 Oct;19(4):301–314. [PubMed] [Google Scholar]
  18. McKelvey E. M., Gottlieb J. A., Wilson H. E., Haut A., Talley R. W., Stephens R., Lane M., Gamble J. F., Jones S. E., Grozea P. N. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 1976 Oct;38(4):1484–1493. doi: 10.1002/1097-0142(197610)38:4<1484::aid-cncr2820380407>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  19. Mead G. M., Harker W. G., Kushlan P., Rosenberg S. A. Single agent palliative chemotherapy for end-stage Hodgkin's disease. Cancer. 1982 Sep 1;50(5):829–835. doi: 10.1002/1097-0142(19820901)50:5<829::aid-cncr2820500504>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  20. Murphy S. B. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980 Sep;7(3):332–339. [PubMed] [Google Scholar]
  21. PETERS M. V., MIDDLEMISS K. C. A study of Hodgkin's disease treated by irradiation. Am J Roentgenol Radium Ther Nucl Med. 1958 Jan;79(1):114–121. [PubMed] [Google Scholar]
  22. Rosenberg S. A., Kaplan H. S. Evidence for an orderly progression in the spread of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1225–1231. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES